Related Experiment Video
Updated: Dec 15, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Nitrogen-Containing Heterocycles as Anticancer Agents: An Overview
Damanpreet K Lang1, Rajwinder Kaur1, Rashmi Arora1
1Chitkara College of Pharmacy, Chitkara University, Punjab, India.
Background:
Cancer is spreading all over the world, and it is becoming the leading cause of major deaths. Today's most difficult task for every researcher is to invent a new drug that can treat cancer with minimal side effects. Many factors, including pollution, modern lifestyle and food habits, exposure to oncogenic agents or radiations, enhanced industrialization, etc. can cause cancer. Treatment of cancer is done by various methods that include chemotherapy, radiotherapy, surgery and immunotherapy in combination or singly along with kinase inhibitors. Most of the anti-cancer drugs use the concept of kinase inhibition.
Objective:
The number of drugs being used in chemotherapy has heterocycles as their basic structure in spite of various side effects. Medicinal chemists are focusing on nitrogen-containing heterocyclic compounds like pyrrole, pyrrolidine, pyridine, imidazole, pyrimidines, pyrazole, indole, quinoline, oxadiazole, azole, benzimidazole, etc. as the key building blocks to develop active biological compounds. The aim of this study is to attempt to compile a dataset of nitrogen-containing heterocyclic anti-cancer drugs.
Methods:
We adopted a structural search on notorious journal publication websites and electronic databases such as Bentham Science, Science Direct, PubMed, Scopus, USFDA, etc. for the collection of peer-reviewed research and review articles for the present review. The quality papers were retrieved, studied, categorized into different sections, analyzed and used for article writing.
Conclusion:
As per FDA databases, nitrogen-based heterocycles in the drug design are almost 60% of unique small-molecule drugs. Some of the nitrogen-containing heterocyclic anti-cancer drugs are Axitinib, Bosutinib, Cediranib, Dasatanib (Sprycel®), Erlotinib (Tarceva®), Gefitinib (Iressa®), Imatinib (Gleevec®), Lapatinib (Tykerb ®), Linifanib, Sorafenib (Nexavar®), Sunitinib (Sutent®), Tivozanib, etc. In the present review, we shall focus on the overview of nitrogen-containing heterocyclic active compounds as anti-cancer agents.
Insights
Nitrogen-containing heterocycles are crucial building blocks for developing novel anti-cancer drugs with fewer side effects. This review compiles a dataset of these vital compounds used in chemotherapy and kinase inhibitors.
Area of Science:
- Medicinal Chemistry
- Oncology
- Drug Discovery
Background:
- Cancer is a leading global cause of death, necessitating new treatments with minimal side effects.
- Current cancer therapies include chemotherapy, radiotherapy, surgery, and immunotherapy, often involving kinase inhibitors.
- Many anti-cancer drugs utilize kinase inhibition as their core mechanism.
Purpose of the Study:
- To compile a dataset of nitrogen-containing heterocyclic anti-cancer drugs.
- To highlight the importance of nitrogen heterocycles in developing novel anti-cancer agents.
- To provide an overview of active nitrogen-containing heterocyclic compounds as anti-cancer agents.
Main Methods:
- Conducted a structural search across major scientific databases (PubMed, Scopus, Science Direct) and regulatory sites (USFDA).
- Collected and reviewed peer-reviewed research and review articles.
- Categorized, analyzed, and synthesized retrieved information for the review.
Main Results:
- Nitrogen-based heterocycles constitute approximately 60% of unique small-molecule drugs approved by the FDA.
- Identified several key nitrogen-containing heterocyclic anti-cancer drugs, including Imatinib, Gefitinib, and Sunitinib.
- Emphasized the role of these heterocycles as fundamental structures in chemotherapy agents.
Conclusions:
- Nitrogen-containing heterocyclic compounds are essential scaffolds in modern anti-cancer drug design.
- These compounds offer a promising avenue for developing more effective cancer therapies with reduced adverse effects.
- The compiled dataset serves as a valuable resource for researchers in medicinal chemistry and oncology.
More Related Videos
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
07:30A Direct, Regioselective and Atom-Economical Synthesis of 3-Aroyl-N-hydroxy-5-nitroindoles by Cycloaddition of 4-Nitronitrosobenzene with Alkynones
Published on: January 21, 2020
Related Concept Videos
Five-Membered Heterocyclic Aromatic Compounds: Overview
Nomenclature of Aryl and Heterocyclic Amines
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
2° Amines to N-Nitrosamines: Reaction with NaNO2
Physical Properties of Amines
Amines: Introduction